Clinical Trials
2 trialsNCT04172402 2025-07-22
NGS as the First-line Treatment in Advanced Biliary Tract Cancer
National Health Research Institutes, Taiwan
Phase 2 Completed
NCT06978114 2025-07-02
A Study of BL-B01D1+PD-1/PD-L1 Monoclonal Antibody in Patients With Advanced Biliary Tract Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2 Recruiting